NEW YORK (GenomeWeb News) – Australian bioseparations products firm NuSep today said that it has signed a letter of intent to acquire US-based mass spectrometry software development firm BioInquire for more than $3 million.

NuSep also said that it has closed a private placement of its shares, raising $830,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.